Inhal Pharma

Ningbo City, China · Founded 2020 · Privately Held (backing)

Developer of a dry powder inhalation platform designed to advance formulation development, inhaler design, and inhaled drug manufacturing. Inhal Pharma is based in Ningbo City, China and was founded in 2020. It has raised $29.5 million.

Last price · $/share

—

Implied valuation

—

Total raised

$29.5M

Last round

—

How much has Inhal Pharma raised?

$29.5Macross 0 recorded rounds

Free account

More of Inhal Pharma with a free account

·The complete investor list: 13 names
·Watch Inhal Pharma: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Inhal Pharma investors

13 investors are on record for Inhal Pharma, including Beijing State-owned Capital Operation and Management, Shun Xi Fund, Saiying Capital and Zhangzhou Pien Tze Huang Investment Management.

For fundraisers

Raising for a company like Inhal Pharma?

13 investors have backed Inhal Pharma.

See all 13 investors →

Frequently asked about Inhal Pharma

How much has Inhal Pharma raised?: Inhal Pharma has raised $29.5M in total across 0 recorded funding rounds.